Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 March 2018 Photo Leonie Bolleurs
Second triumph for young pollution and pharmaceutical researcher
Emmie Chiyindiko, winner of Famelab.

“I am grateful to be reaping the benefits of stepping out of my comfort zone. By facing the unfamiliar, that challenge will allow me to see what great things I am capable of,” said Emmie Chiyindiko, winner of Famelab 2018.

With FameLab, the world’s leading science communication competition, participants have just three minutes to win over the judges and crowd with a scientific talk that excels in content, clarity and charisma. Contestants from around the world participate, armed only with their wits and a few props.

Emmie won the Postgraduate School’s Three-Minute-Thesis competition for master’s level in 2017.

She said: “My research is based on the synthesis and characterisation of a series of unique metal complexes.” These complexes are used both as active pharmaceutical ingredients and cosmetic additives to reduce the detrimental effects of UV radiation on the skin. They are incorporated into anti-ulcer, gastro protective drugs, anti-asthmatic, lung disease drugs, with anti-cancer and anti-diabetic agents,” she said.

With her research she can also monitor air pollution. Formaldehyde is a known toxin to human health. “Using metal complexes, I am able to monitor the production of formaldehyde and consequently come up with exposure prevention methods,” said Emmie.

She believes that it is okay to not ”fit in“. “Mannerisms such as your quirks make you different and distinctive. Live your life intentionally, imprint your personal mark on this universe and always choose faith over fear.”

News Archive

Nano research at the UFS opens door to smart drugs
2011-06-27

 

Prof. Lodewyk Kock, outstanding professor in our Department of Microbial, Biochemical and Food Biotechnology

Novel antifungal, anticancer and anti-malaria drugs that have been identified in the research of Prof. Lodewyk Kock, outstanding professor in the Department of Microbial, Biochemical and Food Biotechnology at our university, will be disclosed later this year at major international conferences in Asia, Europe and the USA. Prof. Kock will be the keynote speaker at these conferences. 

His presentations will be based on the department’s discovery of yeast assays linked to a new nanotechnology for medicine. The assays were recently discovered by his group and can be applied in the development of novel antifungal, anticancer and anti-malaria drugs.
 
Prof. Kock’s focused research at the university, which now also includes his novel nanotechnology for Biology, began in 1982 in collaboration with Prof. Pieter van Wyk (Centre for Microscopy). He recently collaborated with Prof. Hendrik Swart (Department of Physics).
 
Prof. Kock says the development of novel anti-malaria drugs in particular is getting attention across the world due to the high rates of morbidity and mortality caused by the disease worldwide. Approximately 225 million people are infected annually and about a million (many in Africa) die each year. “Many potential smart drugs have been identified with this research and should now be tested further,” says Kock.
  
These new drugs will be disclosed during Prof. Kock’s keynote addresses at the International Conference and Exhibition on Pharmaceutical Regulatory Affairs in Baltimore, USA, from 6 to 7 September 2011, the Medichem 2011 in Beijing, China from 9 to 11 August 2011 and the XVI Congress of European Mycologists in Greece, from 19 to 23 September 2011.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept